Why Soliton Sold Off on Good News from the FDA

As highly anticipated, medical device maker Soliton (SOLY) announced the company received approval from the FDA for the cellulite indication of its Rapid Acoustic Pulse (“RAP”) technology. SOLY initially opened on February 1st with a 17.3% gain, but the stock ended the day with a 3.6% gain. Why did Soliton sell off after this good … Read more

Monster Spike On Mild FDA Letter Setup By Previous Fear-Based Trading

(This is an excerpt from an article I originally published on Seeking Alpha on November 28, 2012. Click here to read the entire piece.) On October 25th, I noted how intrepid traders had loaded up on November $45 puts ahead of news that Monster Beverage Corporation (MNST) was implicated in a lawsuit over the death … Read more